Blood Transfusion
Phagocytic cell line markedly improves survival of infected neutropenic mice
Published in Blood Weekly, October 6th, 2005
According to recent research from the United States, "Disseminated candidiasis is a frequent infection in neutropenic patients, in whom it causes 50% mortality, despite antifungal therapy. As the duration of neutropenia is the strongest predictor of survival in neutropenic patients with invasive fungal infections, neutrophil transfusions are a logical, therapeutic option."
"However, significant technical barriers have prevented the clinical use of neutrophil transfusions. To overcome these barriers, we identified a human phagocytic cell line that could be administered to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-10-06)
More Articles from Blood Weekly
- Blood Banking
Cryopreservation does not affect neural stem cell proliferation and multipotency - Blood Banking
Modified CB collection method achieves sufficient cell levels for transplant - Stem Cell Transplantation
Poor nutritional status prior to SCT associated with increased hospital stay - Stem Cell Transplantation
Transplanted bone marrow cells generate new brain cells - Tissue Engineering
Bone marrow-derived fibroblasts recruited into fibrotic lesions - Acute Myeloid Leukemia
PEP005 has potent antileukemic activity mediated via delta isoform of PKC - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
